Old Web
English
Sign In
Acemap
>
authorDetail
>
Yining Du
Yining Du
Medicine
Nab-paclitaxel
Internal medicine
Gemcitabine
Ruxolitinib
3
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase Ib study of ruxolitinib + gemcitabine ± nab-paclitaxel in patients with advanced solid tumors
2018
OncoTargets and Therapy
Todd Michael Bauer
Manish R. Patel
Andres Forero-Torres
Thomas J. George
Albert Assad
Yining Du
Herbert Hurwitz
Show All
Source
Cite
Save
Citations (8)
A phase 1b study of ruxolitinib (Rux) + gemcitabine (G) ± nab-paclitaxel (N) in patients (pts) with advanced solid tumors.
2017
Journal of Clinical Oncology
Todd Michael Bauer
Manish R. Patel
T. E. Wood
Thomas J. George
Fitzroy W. Dawkins
Kimberli J. Brill
Yining Du
Herbert Hurwitz
Show All
Source
Cite
Save
Citations (0)
Response adaptive randomization and biomarker-based trial designs for addressing patient heterogeneity in personalized medicine
2014
Yining Du
Show All
Source
Cite
Save
Citations (0)
1